Alnylam Pharmaceuticals
ALNY
#1109
Rank
A$31.32 B
Marketcap
A$233.88
Share price
5.41%
Change (1 day)
-66.21%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company